EFSCE
BMRN icon

Enterprise Financial Services Corp (EFSC)’s BioMarin Pharmaceuticals BMRN Stock Holding History

Enterprise Financial Services Corp (EFSC)’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-10
Closed -$1K – 1368
2020
Q4 		$1K Buy
+10
New +$793 ﹤0.01% 1169
2020
Q2 		– Sell
-18
Closed -$2K – 1276
2020
Q1 		$2K Buy
+18
New +$1.55K ﹤0.01% 981
2019
Q3 		– Sell
-25
Closed -$2K – 1132
2019
Q2 		$2K Sell
25
-19
-43% -$1.63K ﹤0.01% 1013
2019
Q1 		$4K Buy
44
+19
+76% +$1.76K ﹤0.01% 936
2018
Q4 		$2K Sell
25
-38
-60% -$3.62K ﹤0.01% 797
2018
Q3 		$6K Buy
63
+38
+152% +$3.79K ﹤0.01% 688
2018
Q2 		$2K Sell
25
-32
-56% -$2.8K ﹤0.01% 844
2018
Q1 		$5K Hold
57
– – ﹤0.01% 712
2017
Q4 		$5K Hold
57
– – ﹤0.01% 690
2017
Q3 		$5K Sell
57
-40
-41% -$3.54K ﹤0.01% 695
2017
Q2 		$9K Sell
97
-140
-59% -$12.7K ﹤0.01% 594
2017
Q1 		$21K Hold
237
– – 0.01% 445
2016
Q4 		$20K Buy
237
+57
+32% +$4.9K 0.01% 441
2016
Q3 		$17K Hold
180
– – 0.01% 447
2016
Q2 		$14K Hold
180
– – 0.01% 471
2016
Q1 		$15K Buy
180
+158
+718% +$12.9K 0.01% 451
2015
Q4 		$2K Hold
22
– – ﹤0.01% 905
2015
Q3 		$2K Hold
22
– – ﹤0.01% 868
2015
Q2 		$3K Sell
22
-74
-77% -$9.17K ﹤0.01% 818
2015
Q1 		$12K Hold
96
– – 0.01% 551
2014
Q4 		$9K Hold
96
– – 0.01% 633
2014
Q3 		$7K Sell
96
-17
-15% -$1.12K ﹤0.01% 678
2014
Q2 		$7K Buy
113
+1
+0.9% +$60 ﹤0.01% 709
2014
Q1 		$8K Hold
112
– – ﹤0.01% 675
2013
Q4 		$8K Hold
112
– – ﹤0.01% 634
2013
Q3 		$8K Buy
112
+13
+13% +$864 0.01% 607
2013
Q2 		$6K Buy
+99
New +$6.17K ﹤0.01% 572

Other funds holding BMRN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Enterprise Financial Services Corp (EFSC)'s BMRN Position: Q1 2021 in Review

Enterprise Financial Services Corp (EFSC) sold out of BioMarin Pharmaceuticals (BMRN) in Q1 2021, closing a stake of 10 shares — an estimated $1K sold.

Enterprise Financial Services Corp (EFSC) first reported a position in BMRN in Q2 2013 and held it in 27 quarters. The position peaked at $21K in Q1 2017. 531 funds tracked by Wall St. Rank hold BMRN as of Q1 2021.

  • Enterprise Financial Services Corp (EFSC) reported no remaining BioMarin Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Enterprise Financial Services Corp (EFSC) sold 10 BioMarin Pharmaceuticals shares in Q1 2021, an estimated $1K.
  • Enterprise Financial Services Corp (EFSC) first reported a position in BioMarin Pharmaceuticals in Q2 2013 and held it in 27 quarters.
  • Enterprise Financial Services Corp (EFSC)'s BioMarin Pharmaceuticals position peaked at $21K in Q1 2017.
  • 531 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2021.

Based on Enterprise Financial Services Corp (EFSC)'s 13F filing for Q1 2021, filed 13 May 2021.